BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8114693)

  • 1. Identification of the functional components of the Ras signaling pathway regulating pituitary cell-specific gene expression.
    Conrad KE; Oberwetter JM; Vaillancourt R; Johnson GL; Gutierrez-Hartmann A
    Mol Cell Biol; 1994 Mar; 14(3):1553-65. PubMed ID: 8114693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene.
    Schweppe RE; Frazer-Abel AA; Gutierrez-Hartmann A; Bradford AP
    J Biol Chem; 1997 Dec; 272(49):30852-9. PubMed ID: 9388230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and Ras regulate gene expression in GH4 pituitary cells by separate, antagonistic signal transduction pathways.
    Pickett CA; Gutierrez-Hartmann A
    Mol Cell Biol; 1995 Dec; 15(12):6777-84. PubMed ID: 8524243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain.
    Bradford AP; Conrad KE; Wasylyk C; Wasylyk B; Gutierrez-Hartmann A
    Mol Cell Biol; 1995 May; 15(5):2849-57. PubMed ID: 7739565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
    Castillo AI; Tolon RM; Aranda A
    Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ras and protein kinase C signaling pathways are functionally antagonistic in GH4 neuroendocrine cells.
    Oberwetter JM; Conrad KE; Gutierrez-Hartmann A
    Mol Endocrinol; 1993 Jul; 7(7):915-23. PubMed ID: 8413316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element.
    Bradford AP; Conrad KE; Tran PH; Ostrowski MC; Gutierrez-Hartmann A
    J Biol Chem; 1996 Oct; 271(40):24639-48. PubMed ID: 8798730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras.
    Lengyel E; Stepp E; Gum R; Boyd D
    J Biol Chem; 1995 Sep; 270(39):23007-12. PubMed ID: 7559439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Gum R; Wang H; Lengyel E; Juarez J; Boyd D
    Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras mediates Src but not epidermal growth factor-receptor tyrosine kinase signaling pathways in GH4 neuroendocrine cells.
    Pickett CA; Gutierrez-Hartmann A
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8612-6. PubMed ID: 8078931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active Gq-alpha stimulates prolactin promoter activity via a pathway involving Raf activity.
    Tian J; Ma HW; Bancroft C
    Mol Cell Endocrinol; 1995 Aug; 112(2):249-56. PubMed ID: 7489829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the P-450 side chain cleavage enzyme (CYP11A1) promoter through ras- and Ets-2-signaling pathways.
    Pestell RG; Albanese C; Watanabe G; Lee RJ; Lastowiecki P; Zon L; Ostrowski M; Jameson JL
    Mol Endocrinol; 1996 Sep; 10(9):1084-94. PubMed ID: 8885243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective repression of rat prolactin gene by stable expression of dominant-negative Ets in GH4 pituitary cells.
    Tentler JJ; Bradford AP; Schweppe RE; Gutierrez-Hartmann A
    Endocrine; 2003; 20(1-2):3-12. PubMed ID: 12668863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.
    Albanese C; Johnson J; Watanabe G; Eklund N; Vu D; Arnold A; Pestell RG
    J Biol Chem; 1995 Oct; 270(40):23589-97. PubMed ID: 7559524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.
    McCarthy SA; Chen D; Yang BS; Garcia Ramirez JJ; Cherwinski H; Chen XR; Klagsbrun M; Hauser CA; Ostrowski MC; McMahon M
    Mol Cell Biol; 1997 May; 17(5):2401-12. PubMed ID: 9111309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
    Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
    Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line.
    Lengyel E; Gum R; Stepp E; Juarez J; Wang H; Boyd D
    J Cell Biochem; 1996 Jun; 61(3):430-43. PubMed ID: 8761947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the Ras suppressor Rsu-1 enhances Erk-2 activation and inhibits Jun kinase activation.
    Masuelli L; Cutler ML
    Mol Cell Biol; 1996 Oct; 16(10):5466-76. PubMed ID: 8816460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human involucrin promoter activity by a protein kinase C, Ras, MEKK1, MEK3, p38/RK, AP1 signal transduction pathway.
    Efimova T; LaCelle P; Welter JF; Eckert RL
    J Biol Chem; 1998 Sep; 273(38):24387-95. PubMed ID: 9733728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.